G6PD Control Intermediate - Indonesia BPOM Medical Device Registration
G6PD Control Intermediate is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20207420140. The device is manufactured by SENTINEL CH. S.P.A from Italy, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is DHH TRADING INDONESIA.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Risk Classification
Product Class
Kelas : 2
Manufacturer
SENTINEL CH. S.P.ACountry of Origin
Italy
Authorized Representative
DHH TRADING INDONESIAAR Address
Revenue Tower 19F, Jl. Jenderal Sudirman No. 52-53, Prov. DKI Jakarta, Kota Adm. Jakarta Selatan, Kec Kebayoran Baru, Kel Senayan
Registration Date
Sep 02, 2024
Expiry Date
Mar 28, 2029
Product Type
Haematology Package and Kit
Erythrocytic glucose-6-phosphate dehydrogenase assay.
Invitro Diagnostics
ALINITY c CRP Vario HS Control Kit
G6PD Control Set
SENTINEL DIAGNOSTIC Standard Hemoglobin Calibrator
G6PD Reagent
G6PD Control Normal
G6PD Control Deficient
SENTINEL Syphilis TP Control Set
SENTINEL Clin Chem Cal
ALINITY c UIBC Calibrator Kit
ALINITY c Creatinine (Enzymatic) Reagent Kit
iQ Calibrator
BECKMAN COULTER, INC.
Iris Diluent Pack
BECKMAN COULTER INC.
BECKMAN COULTER DxU 810c Iris Urine Chemistry Analyzer
BECKMAN COULTER, INC
INFINITY Lithium Reagent for Beckman Coulter AU Chemistry Analyzers
FISHER DIAGNOSTICS
G6PD Control Normal
SENTINEL CH. S.P.A
COULTER TruColor Wright Stain Buffer
POLYSCIENCES INC.
COULTER TruColor Wright Stain
POLYSCIENCES INC.
Access HIV combo V2 QC
BIO-RAD
BECKMAN COULTER Digoxin
MICROGENICS CORPORATION
QMS Tacrolimus Immunoassay
MICROGENICS CORPORATION

